Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.03M Buy
2,850
+200
+8% +$68.5K 0.07% 103
2026
Q1
$932K Sell
2,650
-195
-7% -$69.5K 0.13% 105
2025
Q4
$931K Buy
2,845
+15
+0.5% +$4.76K 0.13% 102
2025
Q3
$799K Hold
2,830
0.11% 108
2025
Q2
$790K Hold
2,830
0.12% 101
2025
Q1
$882K Sell
2,830
-270
-9% -$79.7K 0.17% 93
2024
Q4
$808K Buy
+3,100
New +$920K 0.14% 94

Other funds holding AMGN

Sava Infond's AMGN Position: Q2 2026 in Review

Sava Infond increased its Amgen (AMGN) stake by 7.5% in Q2 2026, buying an estimated $68.5K and bringing the position to 2,850 shares worth $1.03M. The position accounts for 0.07% of the portfolio, ranked #103.

Sava Infond first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Sava Infond held 2,850 shares of Amgen worth $1.03M as of Q2 2026.
  • Sava Infond bought 200 Amgen shares in Q2 2026, an estimated $68.5K.
  • Amgen made up 0.07% of Sava Infond's portfolio in Q2 2026, its #103 holding.
  • Sava Infond first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Sava Infond's 13F filing for Q2 2026, filed 16 Jul 2026.